An AI system at Johns Hopkins has identified a powerful new antibiotic compound from deep-sea bacteria, completing in 3 weeks a process that traditionally takes 3-5 years.
Fighting Superbugs
The compound, dubbed Oceamycin, shows effectiveness against drug-resistant MRSA and other superbugs that kill 1.2 million people annually. It works through a novel mechanism that bacteria haven't developed resistance to.
Accelerated Discovery
The AI screened 12 million bacterial compounds virtually before identifying Oceamycin as the top candidate. Lab tests confirmed its potency within days.
- Effective against 6 drug-resistant bacterial strains
- Human trials expected to begin in late 2026
- AI reduced discovery timeline from years to weeks